124 related articles for article (PubMed ID: 30604632)
21. Insulin-like growth factor 1 is a potent stimulator of cervical cancer cell invasiveness and proliferation that is modulated by alphavbeta3 integrin signaling.
Shen MR; Hsu YM; Hsu KF; Chen YF; Tang MJ; Chou CY
Carcinogenesis; 2006 May; 27(5):962-71. PubMed ID: 16400188
[TBL] [Abstract][Full Text] [Related]
22. [Expression and significance of PTEN/PI3K signal transduction-related proteins in non-small cell lung cancer].
Liao DW; Wang L; Zhang XG; Liu MQ
Ai Zheng; 2006 Oct; 25(10):1238-42. PubMed ID: 17059767
[TBL] [Abstract][Full Text] [Related]
23. Prognostic impact of insulin receptor expression on survival of patients with nonsmall cell lung cancer.
Kim JS; Kim ES; Liu D; Lee JJ; Solis L; Behrens C; Lippman SM; Hong WK; Wistuba II; Lee HY
Cancer; 2012 May; 118(9):2454-65. PubMed ID: 21952750
[TBL] [Abstract][Full Text] [Related]
24. Modulation of response to radiation of human lung cancer cells following insulin-like growth factor 1 receptor inactivation.
Cosaceanu D; Carapancea M; Castro J; Ekedahl J; Kanter L; Lewensohn R; Dricu A
Cancer Lett; 2005 May; 222(2):173-81. PubMed ID: 15863266
[TBL] [Abstract][Full Text] [Related]
25. Metformin Enhances the Therapy Effects of Anti-IGF-1R mAb Figitumumab to NSCLC.
Cao H; Dong W; Qu X; Shen H; Xu J; Zhu L; Liu Q; Du J
Sci Rep; 2016 Aug; 6():31072. PubMed ID: 27488947
[TBL] [Abstract][Full Text] [Related]
26. Reduced expression of EI24 confers resistance to gefitinib through IGF-1R signaling in PC9 NSCLC cells.
Choi JM; Jang JY; Choi YR; Kim HR; Cho BC; Lee HW
Lung Cancer; 2015 Nov; 90(2):175-81. PubMed ID: 26342551
[TBL] [Abstract][Full Text] [Related]
27. FES-related tyrosine kinase activates the insulin-like growth factor-1 receptor at sites of cell adhesion.
Stanicka J; Rieger L; O'Shea S; Cox O; Coleman M; O'Flanagan C; Addario B; McCabe N; Kennedy R; O'Connor R
Oncogene; 2018 Jun; 37(23):3131-3150. PubMed ID: 29540831
[TBL] [Abstract][Full Text] [Related]
28. Expression characteristics of proteins of the insulin-like growth factor axis in non-small cell lung cancer patients with preexisting type 2 diabetes mellitus.
Ding J; Tang J; Chen X; Men HT; Luo WX; Du Y; Ge J; Li C; Chen Y; Cheng K; Qiu M; Liu JY
Asian Pac J Cancer Prev; 2013; 14(10):5675-80. PubMed ID: 24289561
[TBL] [Abstract][Full Text] [Related]
29. Characterization of insulin-like growth factor I receptors and growth effects in human lung cancer cell lines.
Rotsch M; Maasberg M; Erbil C; Jaques G; Worsch U; Havemann K
J Cancer Res Clin Oncol; 1992; 118(7):502-8. PubMed ID: 1320623
[TBL] [Abstract][Full Text] [Related]
30. Oestrogen receptor β5 and epidermal growth factor receptor synergistically promote lung cancer progression.
Bai Y; Shen W; Zhang L; Yang Z; Xiong L; Tang H; Zhao J
Autoimmunity; 2018 Jun; 51(4):157-165. PubMed ID: 30022688
[TBL] [Abstract][Full Text] [Related]
31. Comparison of three approaches for inhibiting insulin-like growth factor I receptor and their effects on NSCLC cell lines in vitro.
Cosaceanu D; Carapancea M; Alexandru O; Budiu R; Martinsson HS; Starborg M; Vrabete M; Kanter L; Lewensohn R; Dricu A
Growth Factors; 2007 Feb; 25(1):1-8. PubMed ID: 17454144
[TBL] [Abstract][Full Text] [Related]
32. IGF1/IGF1R/STAT3 signaling-inducible IFITM2 promotes gastric cancer growth and metastasis.
Xu L; Zhou R; Yuan L; Wang S; Li X; Ma H; Zhou M; Pan C; Zhang J; Huang N; Shi M; Bin J; Liao Y; Liao W
Cancer Lett; 2017 May; 393():76-85. PubMed ID: 28223169
[TBL] [Abstract][Full Text] [Related]
33. Curcumol induces cell cycle arrest and apoptosis by inhibiting IGF-1R/PI3K/Akt signaling pathway in human nasopharyngeal carcinoma CNE-2 cells.
Li X; Liu H; Wang J; Qin J; Bai Z; Chi B; Yan W; Chen X
Phytother Res; 2018 Nov; 32(11):2214-2225. PubMed ID: 30069933
[TBL] [Abstract][Full Text] [Related]
34. B-Myb Mediates Proliferation and Migration of Non-Small-Cell Lung Cancer via Suppressing IGFBP3.
Fan X; Wang Y; Jiang T; Cai W; Jin Y; Niu Y; Zhu H; Bu Y
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772705
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of IGF-1R in lung cancer: A PRISMA-compliant meta-analysis.
Xu J; Bie F; Wang Y; Chen X; Yan T; Du J
Medicine (Baltimore); 2019 May; 98(19):e15467. PubMed ID: 31083179
[TBL] [Abstract][Full Text] [Related]
36. The prognostic significance of pretreatment plasma levels of insulin-like growth factor (IGF)-1, IGF-2, and IGF binding protein-3 in patients with advanced non-small cell lung cancer.
Han JY; Choi BG; Choi JY; Lee SY; Ju SY
Lung Cancer; 2006 Nov; 54(2):227-34. PubMed ID: 16935391
[TBL] [Abstract][Full Text] [Related]
37. Resistance to interleukin 6 in human non-small cell lung carcinoma cell lines: role of receptor components.
Ganapathi MK; Weizer AK; Borsellino S; Bukowski RM; Ganapathi R; Rice T; Casey G; Kawamura K
Cell Growth Differ; 1996 Jul; 7(7):923-9. PubMed ID: 8809410
[TBL] [Abstract][Full Text] [Related]
38. The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer.
Al-Saad S; Richardsen E; Kilvaer TK; Donnem T; Andersen S; Khanehkenari M; Bremnes RM; Busund LT
PLoS One; 2017; 12(7):e0181527. PubMed ID: 28742836
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
[TBL] [Abstract][Full Text] [Related]
40. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
